Prevalence of subclinical atheromatosis and associated risk factors in chronic kidney disease: the NEFRONA study
Authors:
- Montserrat Martinez-AlonsoMMMontserrat Martinez-Alonso
- Maria Vittoria ArcidiaconoMAMaria Vittoria Arcidiacono
- Jorge Cannata-AndiaJCJorge Cannata-Andia
- José Manuel ValdivielsoJVJosé Manuel Valdivielso
- on behalf of the investigators from the NEFRONA studyOSon behalf of the investigators from the NEFRONA study
Open Access
- 28 February 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 29 (7) , 1415-1422
Abstract
The causes of the high cardiovascular mortality observed in chronic kidney disease (CKD) are unknown. Here, we report data on prevalence of subclinical atherosclerosis in the NEFRONA population and a stratified multivariate logistic analysis of factors associated with the presence of plaque. We analysed 2445 patients with an estimated glomerular filtration rate (eGFR) 60 mL/min), 18–75 years old, without previous cardiovascular events. An itinerant team of professionals performed carotid and femoral arterial ultrasound. The already high prevalence of plaques in CKD 3 is even higher in more severe CKD. Multivariate logistic analysis showed that, at any CKD stage, age and being male are independently associated with the presence of plaques. In CKD 3, there was a significant interaction of the smoking status and triglycerides levels which were independently associated with the presence of plaque. Furthermore, being diabetic was also associated with the presence of subclinical atherosclerosis. In stage 4–5 there was a significant association with smoking, high phosphate and hsCRP levels. In dialysis patients, being diabetic, having low levels of 25(OH)-vitamin D3 and smoking status also showed a significant association with the presence of plaque. Furthermore, the association of phosphate levels with the presence of subclinical atheromatosis showed a U-shaped curve. This analysis demonstrates the magnitude of subclinical atheromatous disease in a large CKD population. The patient characteristics associated with the presence of plaque differ in every CKD stage.Keywords
This publication has 33 references indexed in Scilit:
- Impact of Estimated Glomerular Filtration Rate on Vascular Disease Extent and Adverse Cardiovascular Events in Patients Without Chronic Kidney DiseaseCanadian Journal of Cardiology, 2013
- Carotid-Wall Intima–Media Thickness and Cardiovascular EventsNew England Journal of Medicine, 2011
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trialThe Lancet, 2011
- Predicting cardiovascular disease morbidity and mortality in chronic kidney disease in Spain. The rationale and design of NEFRONA: a prospective, multicenter, observational cohort studyBMC Nephrology, 2010
- Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysisThe Lancet, 2010
- Carotid Intima-Media Thickness and Presence or Absence of Plaque Improves Prediction of Coronary Heart Disease RiskJACC, 2010
- Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery diseaseKidney International, 2009
- Smoking, inflammatory patterns and postprandial hypertriglyceridemiaAtherosclerosis, 2009
- Effect of Rosuvastatin on Outcomes in Chronic Haemodialysis Patients: Baseline Data from the AURORA StudyKidney and Blood Pressure Research, 2007
- Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patientsKidney International, 2006